Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
Australia
South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street,, Southport, Gold Coast Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive, Liverpool, New South Wales Sydney Adventist Hospital, Wahroonga, New South Wales Westmead Hospital, Clinical Research Unit, Level 6, B Wing/Building, Hawkesbury Road, Westmead, New South Wales Mater Hospital Brisbane, South Brisbane, Queensland